0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  May 01, 2013
Effects of Varenicline and Bupropion Sustained-Release Use Plus Intensive Smoking Cessation Counseling on Prolonged Abstinence From Smoking and on Depression, Negative Affect, and Other Symptoms of Nicotine Withdrawal
Paul M. Cinciripini, PhD; Jason D. Robinson, PhD; Maher Karam-Hage, MD; et al.
JAMA Psychiatry. 2013;70(5):522-533. doi:10.1001/jamapsychiatry.2013.678.
Original Article |  April 01, 2013
The Sertraline vs Electrical Current Therapy for Treating Depression Clinical Study:  Results From a Factorial, Randomized, Controlled Trial
Andre R. Brunoni, MD, PhD; Leandro Valiengo, MD; Alessandra Baccaro, BA; et al.
JAMA Psychiatry. 2013;70(4):383-391. doi:10.1001/2013.jamapsychiatry.32.
INCLUDES: , Supplemental Content
Original Article |  April 01, 2013
Antidepressants Normalize the Default Mode Network in Patients With Dysthymia
Jonathan Posner, MD; David J. Hellerstein, MD; Inbal Gat, BA; et al.
JAMA Psychiatry. 2013;70(4):373-382. doi:10.1001/jamapsychiatry.2013.455.
INCLUDES: CME , Supplemental Content
Meta-analysis |  April 01, 2013
Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication:  A Systematic Review and Meta-analysis
Lori E. Ross, PhD; Sophie Grigoriadis, MD, MA, PhD, FRCPC; Lana Mamisashvili, MSW; et al.
JAMA Psychiatry. 2013;70(4):436-443. doi:10.1001/jamapsychiatry.2013.684.
INCLUDES: , Supplemental Content
Original Article |  March 01, 2013
Potential of Pretreatment Neural Activity in the Visual Cortex During Emotional Processing to Predict Treatment Response to Scopolamine in Major Depressive Disorder
Maura L. Furey, PhD; Wayne C. Drevets, MD; Elana M. Hoffman, BA; et al.
JAMA Psychiatry. 2013;70(3):280-290. doi:10.1001/2013.jamapsychiatry.60.
INCLUDES: , Supplemental Content
Original Article |  January 01, 2013
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression:  The Role of Baseline Inflammatory Biomarkers
Charles L. Raison, MD; Robin E. Rutherford, MD; Bobbi J. Woolwine, MSW; et al.
JAMA Psychiatry. 2013;70(1):31-41. doi:10.1001/2013.jamapsychiatry.4.
INCLUDES: , Supplemental Content
Original Article |  December 01, 2012
National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics
Mark Olfson, MD, MPH; Carlos Blanco, MD, PhD; Shang-Min Liu, MS; et al.
Arch Gen Psychiatry. 2012;69(12):1247-1256. doi:10.1001/archgenpsychiatry.2012.647.
INCLUDES: , Supplemental Content
Original Article |  December 01, 2012
Improvement of Brain Reward Abnormalities by Antipsychotic Monotherapy in Schizophrenia
Mette Odegaard Nielsen, MD, PhD; Egill Rostrup, MD, DMSc; Sanne Wulff, MD; et al.
Arch Gen Psychiatry. 2012;69(12):1195-1204. doi:10.1001/archgenpsychiatry.2012.847.
INCLUDES: , Supplemental Content
Original Article |  December 01, 2012
Neural Correlates of Weight Gain With Olanzapine
Jose Mathews, MD; John W. Newcomer, MD; Jennifer R. Mathews, PhD; et al.
Arch Gen Psychiatry. 2012;69(12):1226-1237. doi:10.1001/archgenpsychiatry.2012.934.
INCLUDES: , Supplemental Content
Original Article |  September 01, 2012
Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder
Kurt P. Schulz, PhD; Jin Fan, PhD; Anne-Claude V. Bédard, PhD; et al.
Arch Gen Psychiatry. 2012;69(9):952-961. doi:10.1001/archgenpsychiatry.2011.2053.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 29, 2013
Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery
Andrew D. Auerbach, MD, MPH; Eric Vittinghoff, PhD; Judith Maselli, MSPH; et al.
JAMA Internal Medicine
Invited Commentary  |  April 29, 2013
Selective Serotonin Reuptake Inhibitors and Surgery: To Hold or Not to Hold, That Is the Question:  Comment on “Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery”
Marko Mrkobrada, MD, FRCPC; Daniel G. Hackam, MD, PhD, FRCPC
JAMA Internal Medicine
Review Article  |  March 4, 2013
Pharmacologic Therapy for Primary Restless Legs Syndrome:  A Systematic Review and Meta-analysis
Timothy J. Wilt, MD, MPH; Roderick MacDonald, MS; Jeannine Ouellette; et al.
JAMA
Original Contribution  |  April 03, 2013
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy:  A Randomized Clinical Trial
Ellen M. Lavoie Smith, PhD; Herbert Pang, PhD; Constance Cirrincione, MS; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems